| Style | Citing Format |
|---|---|
| MLA | Akhavan S, et al.. "Comparing Intranasal Midazolam, Oral Melatonin, and Distraction Cards for Pain and Stress Management in Pediatric Intravenous Line Insertion: A Randomized Controlled Trial." Pain Research and Management, vol. 2026, no. 1, 2026, pp. -. |
| APA | Akhavan S, Shah Hosseini S, Amini N, Saeidi M (2026). Comparing Intranasal Midazolam, Oral Melatonin, and Distraction Cards for Pain and Stress Management in Pediatric Intravenous Line Insertion: A Randomized Controlled Trial. Pain Research and Management, 2026(1), -. |
| Chicago | Akhavan S, Shah Hosseini S, Amini N, Saeidi M. "Comparing Intranasal Midazolam, Oral Melatonin, and Distraction Cards for Pain and Stress Management in Pediatric Intravenous Line Insertion: A Randomized Controlled Trial." Pain Research and Management 2026, no. 1 (2026): -. |
| Harvard | Akhavan S et al. (2026) 'Comparing Intranasal Midazolam, Oral Melatonin, and Distraction Cards for Pain and Stress Management in Pediatric Intravenous Line Insertion: A Randomized Controlled Trial', Pain Research and Management, 2026(1), pp. -. |
| Vancouver | Akhavan S, Shah Hosseini S, Amini N, Saeidi M. Comparing Intranasal Midazolam, Oral Melatonin, and Distraction Cards for Pain and Stress Management in Pediatric Intravenous Line Insertion: A Randomized Controlled Trial. Pain Research and Management. 2026;2026(1):-. |
| BibTex | @article{ author = {Akhavan S and Shah Hosseini S and Amini N and Saeidi M}, title = {Comparing Intranasal Midazolam, Oral Melatonin, and Distraction Cards for Pain and Stress Management in Pediatric Intravenous Line Insertion: A Randomized Controlled Trial}, journal = {Pain Research and Management}, volume = {2026}, number = {1}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Akhavan S AU - Shah Hosseini S AU - Amini N AU - Saeidi M TI - Comparing Intranasal Midazolam, Oral Melatonin, and Distraction Cards for Pain and Stress Management in Pediatric Intravenous Line Insertion: A Randomized Controlled Trial JO - Pain Research and Management VL - 2026 IS - 1 SP - EP - PY - 2026 ER - |